BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9159660)

  • 1. Treatment of non-insulin-dependent diabetes mellitus with metformin.
    Guthrie R
    J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of metformin in the treatment of type 2 diabetes mellitus.
    Davidson MB; Peters AL
    Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: a new oral biguanide.
    Campbell RK; White JR; Saulie BA
    Clin Ther; 1996; 18(3):360-71; discussion 359. PubMed ID: 8829014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in noninsulin-dependent diabetes mellitus.
    Lee AJ
    Pharmacotherapy; 1996; 16(3):327-51. PubMed ID: 8726592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin: a safe and effective treatment in the management of NIDDM.
    Kilo C
    Mo Med; 1997 Mar; 94(3):114-23. PubMed ID: 9071866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: an antihyperglycemic agent for treatment of type II diabetes.
    Melchior WR; Jaber LA
    Ann Pharmacother; 1996 Feb; 30(2):158-64. PubMed ID: 8835050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L; Widén E
    Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes.
    Johnson M; Krosnick A; Carson P; McDade AM; Laraway K
    Clin Ther; 1998; 20(4):691-8. PubMed ID: 9737829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
    Dunn CJ; Peters DH
    Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiology.
    Koliaki C; Doupis J
    Adv Ther; 2012 Dec; 29(12):993-1004. PubMed ID: 23184570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
    Setter SM; Iltz JL; Thams J; Campbell RK
    Clin Ther; 2003 Dec; 25(12):2991-3026. PubMed ID: 14749143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin hydrochloride: an antihyperglycemic agent.
    Klepser TB; Kelly MW
    Am J Health Syst Pharm; 1997 Apr; 54(8):893-903. PubMed ID: 9114921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic utility of biguanides in the treatment of NIDDM].
    Fujimoto S
    Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.